510(k) Report

510(k) · Cleared

Cleared

Easy Plus II Blood Glucose Monitoring System,Easy Plus II Multi Blood Glucose Monitoring System,Smartest Persona II Bloo

K133509510(k) SpecialCleared Feb 21, 201499-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biotest Medical Corp. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Feb 21, 2014 as substantially equivalent to K100560 (Biotest Medical Corp., 2010) after a 99-day review. Its family tree reaches back 5 generations to 2004.

Decided
Feb 21, 2014
Review
99 days
Class
Class II
Product code
NBW
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K042005 (2004). No later device cites it as a predicate yet.

  1. Root · 5 generations backK042005 Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222Taidoc Technology Corporation · 2004
  2. 4 generations backK060467 Prodigy Blood Glucose Test SystemDiagnostic Devices, Inc. · 2006
  3. 3 generations backK073118 Prodigy Voice Blood Glucose Monitoring SystemDiagnostic Devices, Inc. · 2008
  4. 2 generations backK091815 Supercheck 1 Blood Glucose Monitoring System, Model 6268Biotest Medical Corp. · 2009
  5. 1 generation backK100560 Easy Talk Blood Glucose Monitoring System Model: 6277Biotest Medical Corp. · 2010
  6. This deviceK133509 Easy Plus II Blood Glucose Monitoring System,Easy Plus II Multi…Biotest Medical Corp. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K042005Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222Taidoc Technology Corporation2004—
−4K060467Prodigy Blood Glucose Test SystemDiagnostic Devices, Inc.2006—
−3K073118Prodigy Voice Blood Glucose Monitoring SystemDiagnostic Devices, Inc.2008—
−2K091815Supercheck 1 Blood Glucose Monitoring System, Model 6268Biotest Medical Corp.2009—
−1K100560Easy Talk Blood Glucose Monitoring System Model: 6277Biotest Medical Corp.2010—
0 (this device)K133509Easy Plus II Blood Glucose Monitoring System,Easy Plus II Multi Blood Glucose…Biotest Medical Corp.2014—
FIG. 1 — Lineage of K133509, 2004–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K100560Easy Talk Blood Glucose Monitoring System Model: 6277
Summary page 6
…manuals were written to make the devices easy to use. 8. Conclusion Modifications to the cleared device, Easy Talk Blood Glucose Monitoring System, Model 6277 (K100560), include voice feature change from talking to, non-talking and housing design. In summary, the Easy Plus 11(6276-5), Easy Plus…
Biotest Medical Corp.2010—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 1.7 years on median.
  • None of the 5 ancestors has a recall.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The Easy Plus 11 Blood Glucose Monitoring System Model 6276-S is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the finger and the forearm. The Easy Plus 11 Blood Glucose Monitoring System Model 6276-S is intended to be used by a single person and should not be shared. The Easy Plus 11 Blood Glucose Monitoring System Model 6276-S is intended for self-testing outside the body(in vitro diagnostic…

Read the full statement (824 words)

The Easy Plus 11 Blood Glucose Monitoring System Model 6276-S is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the finger and the forearm. The Easy Plus 11 Blood Glucose Monitoring System Model 6276-S is intended to be used by a single person and should not be shared. The Easy Plus 11 Blood Glucose Monitoring System Model 6276-S is intended for self-testing outside the body(in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control program. The Easy Plus 11 Blood Glucose Monitoring System Model 6276-S should not be used for the diagnosis of or screening of diabetes or for neonatal use. Alternative site testing should be done only during steady state times (when glucose in not changing rapidly).

The Easy Plus 11 Test Strips are for use with the Easy Plus 11 Blood Glucose Meter to quantitatively measure glucose in fresh capillary whole blood drawn from the finger and the forearm.

The Easy Plus 11 Control Solutions are for use with the Easy Plus 11Blood Glucose Monitoring System Model 6276-S as a quality control check to verify that the meter and test strips are working together properly.

The Easy Plus 11 Multi Blood Glucose Monitoring System Model 6276-U is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the finger and the forearm. The Easy Plus 11Multi Blood Glucose Monitoring System Model 6276-M is intended for testing outside the body (in vitro diagnostic use) and is intended for multiple-patient use in a profession healthcare setting as an aid to monitor the effectiveness of a diabetes control programi. This system should only be used with single-use, auto-disabling lancets. The Easy Plus 11 Multi Blood Glucose Monitoring System Model 6276-M should not be used for the diagnosis of or screening of diabetes or for neonatal use. Alternative site testing should be done only during steady state times (when glucose in not changing rapidly).

The Easy Plus 11 Multi Test Strips are for use with the Easy Plus 11 Blood Glucose Multi Meter to quantitatively measure glucose in fresh capillary whole blood drawn from the finger and the forearm.

The Easy Plus 11 Multi Control Solutions are for use with the Easy Plus 11 Multi Blood Glucose Monitoring System Model 6276-M as aquality control check to verify that the meter and test strips are working together properly.

The Smartest Persona 11 Blood Glucose Monitoring System Model 6276-S is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the finger and the forearm. The Smartest Persona II Blood Glucose Monitoring System Model 6276-S is intended to be used by a single person and should not be shared. The Smartest Persona 11 Blood Glucose Monitoring System Model 6276-S is intended for self-testing outside the body(in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control. The Smartest Persona 11 Blood Glucose Monitoring System Model 6276-S should not be used for the diagnosis of or screening of diabetes or for neonatal use. Alternative site testing should be done only during steady state times (when glucose in not changing rapidly).

The Smartest Persona 11 Test Strips are for use with the Smartest Persona 11 Blood Glucose Meter to quantitatively measure glucose in fresh capillary whole blood drawn from the finger and the forearm.

The Smartest Persona 11 Control Solutions are for use with the Smartest Persona 11Blood Glucose Monitoring System Model 6276-S asa quality control check to verify that the meter and test strips are working together properly.

The Smartest Persona 11 Multi Blood Glucose Monitoring System Model 6276-M is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the finger and the forearm. The Smartest Persona 11 Multi Blood Glucose Monitoring System Model 6276-M is intended for testing outside the body (in vitro diagnostic use) and is intended for multiple-patient use in a profession healthcare setting as an aid to monitor the effectiveness of a diabetes control program. This system should only be used with single-use, auto-disabling lancets. The Smartest Persona 11 Multi Blood Glucose Monitoring System Model 6276-M should not be used for the diagnosis of or screening of diabetes or for neonatal use. Alternative site testing should be done only during steady state times (when glucose in not changing rapidly).

The Smartest Persona 11 Multi Test Strips are for use with the Smartest Persona 11 Blood Glucose Multi Meter to quantitatively measure glucose in fresh capillary whole blood drawn from the finger and the forearm.

The Smartest Persona 11 Multi Control Solutions are for use with the Smartest Persona 11 Multi Blood Glucose Monitoring System Model 6276-M as a quality control check to verify that the meter and test strips are working together properly.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K133509: Easy Plus II Blood Glucose Monitoring System,Easy Plus II Multi Blood Glucose Monitoring System,Smartest Persona II Bloo.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K133509

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026